Limited role for lymphotoxin a in the host immune response to Mycobacterium tuberculosis

Journal of Immunology

Volumn 185, Issue 7, 2010, Pages 4292-4301

  Allie, Nasiema ^a   Keeton, Roanne ^a   Court, Nathalie ^c   Abel, Brian ^a   Fick, Lizette ^a   Vasseur, Virginie ^c   Vacher, Rachel ^c   Olleros, Maria L ^d   Drutskaya, Marina S ^e   Guler, Reto ^a,d   Nedospasov, Sergei A ^e,f   Garcia, Irene ^d   Ryffel, Bernhard ^a,c   Quesniaux, Valerie F J ^a   Jacobs, Muazzam ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Department of Human Genetics   (South Africa)

^c UNIVERSITÉ D'ORLÉANS   (France)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^f Leibniz Institute   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; LYMPHOTOXIN; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MARROW; COMPARATIVE STUDY; CONTROLLED STUDY; EX VIVO STUDY; GRANULOMA; HEMATOPOIETIC CELL; IMMUNE RESPONSE; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TH1 CELL; TUBERCULOSIS; WILD TYPE; ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT;

ANIMALS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; LYMPHOTOXIN-ALPHA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE SYNTHASE TYPE II; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77958117397     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000650     Document Type: Review

References (42)

1. Raychaudhuri, S. P., C. T. Nguyen, S. K. Raychaudhuri, and M. E. Gershwin. 2009. Incidence and nature of infectious disease in patients treated with anti-TNF agents. Autoimmun. Rev. 9:67-81.
2. Scallon, B., A. Cai, N. Solowski, A. Rosenberg, X. Y. Song, D. Shealy, and C. Wagner. 2002. Binding and functional comparisons of two types of tumor necrosis factor antagonists. J. Pharmacol. Exp. Ther. 301:418-426.
3. Plessner, H. L., P. L. Lin, T. Kohno, J. S. Louie, D. Kirschner, J. Chan, and J. L. Flynn. 2007. Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis. J. Infect. Dis. 195:1643-1650.
4. Tracey, D., L. Klareskog, E. H. Sasso, J. G. Salfeld, and P. P. Tak. 2008. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol. Ther. 117:244-279.
5. Locksley, R. M., N. Killeen, and M. J. Lenardo. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487-501.
6. Grivennikov, S. I., D. V. Kuprash, Z. G. Liu, and S. A. Nedospasov. 2006. Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: from simple paradigms to complex mechanisms. Int. Rev. Cytol. 252:129-161.
7. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.
8. Grivennikov, S. I., A. V. Tumanov, D. J. Liepinsh, A. A. Kruglov, B. I. Marakusha, A. N. Shakhov, T. Murakami, L. N. Drutskaya, I. Förster, B. E. Clausen, et al. 2005. Distinct and nonredundant in vivo functions of TNF produced by T cells and macrophages/neutrophils: protective and deleterious effects. Immunity 22:93-104.
9. Perez, C., I. Albert, K. De Fay, N. Zachariades, L. Gooding, and M. Kriegler. 1990. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63:251-258.
10. Orlinick, J. R., and M. V. Chao. 1998. TNF-related ligands and their receptors. Cell. Signal. 10:543-551.
11. Fu, Y. X., and D. D. Chaplin. 1999. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17:399-433.
12. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNF-a-deficient mice: a critical requirement for TNF-a in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397-1411.
13. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, et al. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093-8098.
14. Kuprash, D. V., A. V. Tumanov, D. J. Liepinsh, E. P. Koroleva, M. S. Drutskaya, A. A. Kruglov, A. N. Shakhov, E. Southon, W. J. Murphy, L. Tessarollo, et al. 2005. Novel tumor necrosis factor-knockout mice that lack Peyer's patches. Eur. J. Immunol. 35:1592-1600.
15. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-a is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572.
16. Bean, A. G., D. R. Roach, H. Briscoe, M. P. France, H. Korner, J. D. Sedgwick, and W. J. Britton. 1999. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162:3504-3511.
17. Botha, T., and B. Ryffel. 2003. Reactivation of latent tuberculosis infection in TNF-deficient mice. J. Immunol. 171:3110-3118.
18. Jacobs, M., N. Brown, N. Allie, and B. Ryffel. 2000. Fatal Mycobacterium bovis BCG infection in TNF-LT-α-deficient mice. Clin. Immunol. 94:192-199.
19. Bopst, M., I. Garcia, R. Guler, M. L. Olleros, T. Rülicke, M. Müller, S. Wyss, K. Frei, M. Le Hir, and H. P. Eugster. 2001. Differential effects of TNF and LTa in the host defense against M. bovis BCG. Eur. J. Immunol. 31:1935-1943.
20. Roach, D. R., H. Briscoe, B. Saunders, M. P. France, S. Riminton, and W. J. Britton. 2001. Secreted lymphotoxin-a is essential for the control of an intracellular bacterial infection. J. Exp. Med. 193:239-246.
21. Alexopoulou, L., M. Pasparakis, and G. Kollias. 1998. Complementation of lymphotoxin alpha knockout mice with tumor necrosis factor-expressing transgenes rectifies defective splenic structure and function. J. Exp. Med. 188:745-754.
22. Liepinsh, D. J., S. I. Grivennikov, K. D. Klarmann, M. A. Lagarkova, M. S. Drutskaya, S. J. Lockett, L. Tessarollo, M. McAuliffe, J. R. Keller, D. V. Kuprash, and S. A. Nedospasov. 2006. Novel lymphotoxin a (LTa) knockout mice with unperturbed tumor necrosis factor expression: reassessing LTalpha biological functions. Mol. Cell. Biol. 26:4214-4225.
23. Banks, T. A., B. T. Rouse, M. K. Kerley, P. J. Blair, V. L. Godfrey, N. A. Kuklin, D. M. Bouley, J. Thomas, S. Kanangat, and M. L. Mucenski. 1995. Lymphotoxin-a-deficient mice: effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155:1685-1693.
24. Guler, R., M. L. Olleros, D. Vesin, R. Parapanov, C. Vesin, S. Kantengwa, L. Rubbia-Brandt, N. Mensi, A. Angelillo-Scherrer, E. Martinez-Soria, et al. 2004. Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J. Hepatol. 41:773-781.
25. Wakeham, J., J. Wang, J. Magram, K. Croitoru, R. Harkness, P. Dunn, A. Zganiacz, and Z. Xing. 1998. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guérin in IL-12-deficient mice. J. Immunol. 160:6101-6111.
26. Müller, M., H. P. Eugster, M. Le Hir, A. Shakhov, F. Di Padova, C. Maurer, V. F. Quesniaux, and B. Ryffel. 1996. Correction or transfer of immunodeficiency due to TNF-LTα deletion by bone marrow transplantation. Mol. Med. 2:247-255.
27. Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740.
28. MacMicking, J. D., R. J. North, R. La Course, J. S. Mudgett, S. K. Shah, and C. F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243-5248.
29. Lucas, R., F. Tacchini-Cottier, R. Guler, D. Vesin, S. Jemelin, M. L. Olleros, G. Marchal, J. L. Browning, P. Vassalli, and I. Garcia. 1999. A role for lymphotoxin β receptor in host defense against Mycobacterium bovis BCG infection. Eur. J. Immunol. 29:4002-4010.
30. Fremond, C. M., V. Yeremeev, D. M. Nicolle, M. Jacobs, V. F. Quesniaux, and B. Ryffel. 2004. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J. Clin. Invest. 114:1790-1799.
31. Fremond, C. M., D. Togbe, E. Doz, S. Rose, V. Vasseur, I. Maillet, M. Jacobs, B. Ryffel, and V. F. Quesniaux. 2007. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol. 179:1178-1189.
32. Sean Riminton, D., H. Körner, D. H. Strickland, F. A. Lemckert, J. D. Pollard, and J. D. Sedgwick. 1998. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J. Exp. Med. 187:1517-1528.
33. Engwerda, C. R., M. Ato, S. Stäger, C. E. Alexander, A. C. Stanley, and P. M. Kaye. 2004. Distinct roles for lymphotoxin-a and tumor necrosis factor in the control of Leishmania donovani infection. Am. J. Pathol. 165:2123-2133.
34. Engwerda, C. R., T. L. Mynott, S. Sawhney, J. B. De Souza, Q. D. Bickle, and P. M. Kaye. 2002. Locally upregulated lymphotoxin a, not systemic tumor necrosis factor a, is the principle mediator of murine cerebral malaria. J. Exp. Med. 195:1371-1377.
35. Togbe, D., P. L. de Sousa, M. Fauconnier, V. Boissay, L. Fick, S. Scheu, K. Pfeffer, R. Menard, G. E. Grau, B. T. Doan, et al. 2008. Both functional LTb receptor and TNF receptor 2 are required for the development of experimental cerebral malaria. PLoS One 3: e2608.
36. Ehlers, S., C. Hölscher, S. Scheu, C. Tertilt, T. Hehlgans, J. Suwinski, R. Endres, and K. Pfeffer. 2003. The lymphotoxin beta receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes. J. Immunol. 170:5210-5218.
37. Olleros, M. L., R. Guler, N. Corazza, D. Vesin, H. P. Eugster, G. Marchal, P. Chavarot, C. Mueller, and I. Garcia. 2002. Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-a. J. Immunol. 168:3394-3401.
38. Schlüter, D., L. Y. Kwok, S. Lütjen, S. Soltek, S. Hoffmann, H. Körner, and M. Deckert. 2003. Both lymphotoxin-a and TNF are crucial for control of Toxoplasma gondii in the central nervous system. J. Immunol. 170:6172-6182.
39. Clay, H., H. E. Volkman, and L. Ramakrishnan. 2008. Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity 29:283-294.
40. Lin, P. L., A. Myers, L. Smith, C. Bigbee, M. Bigbee, C. Fuhrman, H. Grieser, I. Chiosea, N. N. Voitenek, S. V. Capuano, et al. 2010. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum. 62:340-350.
41. Egen, J. G., A. G. Rothfuchs, C. G. Feng, N. Winter, A. Sher, and R. N. Germain. 2008. Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 28:271-284.
42. Kuprash, D. V., I. A. Udalova, R. L. Turetskaya, D. Kwiatkowski, N. R. Rice, and S. A. Nedospasov. 1999. Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide. J. Immunol. 162:4045-4052.